Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to -$360000.0.

  • Dianthus Therapeutics' Other Non Operating Income fell 65000.0% to -$360000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$947000.0, marking a year-over-year decrease of 24562.04%. This contributed to the annual value of -$554000.0 for FY2024, which is 55176.47% down from last year.
  • Latest data reveals that Dianthus Therapeutics reported Other Non Operating Income of -$360000.0 as of Q3 2025, which was down 65000.0% from -$107000.0 recorded in Q2 2025.
  • In the past 5 years, Dianthus Therapeutics' Other Non Operating Income ranged from a high of $56000.0 in Q3 2022 and a low of -$382000.0 during Q4 2024
  • Its 4-year average for Other Non Operating Income is -$95230.8, with a median of -$48000.0 in 2024.
  • As far as peak fluctuations go, Dianthus Therapeutics' Other Non Operating Income tumbled by 116666.67% in 2024, and later surged by 1403.51% in 2025.
  • Dianthus Therapeutics' Other Non Operating Income (Quarter) stood at -$20000.0 in 2022, then crashed by 60.0% to -$32000.0 in 2023, then tumbled by 1093.75% to -$382000.0 in 2024, then grew by 5.76% to -$360000.0 in 2025.
  • Its Other Non Operating Income stands at -$360000.0 for Q3 2025, versus -$107000.0 for Q2 2025 and -$98000.0 for Q1 2025.